[ad_1] AMSTERDAM – HIV vaccine candidates produced immune responses that lasted at least a year after the last shot, a researcher said here. The Randomized Phase I / IIa Analysis According to …
Read More »The HIV vaccine candidate produces a robust immune response in healthy adults
[ad_1] An experimental vaccine regimen against HIV-1, adenovirus mosaic serotype 26 (Ad26) was well tolerated and produced immune responses against HIV in humans and rhesus monkeys, according to the results of one …
Read More »